Ocular Therapeutix, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €445.71M +148.9% €41.94M -127.5% 9.4% +0.95 pp N/A N/A
    (estimated) €179.04M +116.5% -€152.66M -25.7% -85.3% +1.6 pp N/A N/A
    (estimated) €82.71M +48.6% -€205.40M -15.3% -248.3% +1.9 pp N/A N/A
    (estimated) €55.66M +17.3% -€242.53M +6.5% -435.7% +0.44 pp N/A N/A
    (estimated) €47.45M -13.6% -€227.67M +36.6% -479.9% -1.8 pp N/A N/A
    €54.90M +9.0% -€166.71M +139.7% -303.7% -1.7 pp -€114.92M +107.9% -209.3% -1.0 pp
    €50.35M +13.5% -€69.56M +27.3% -138.1% -0.15 pp -€55.27M +14.8% -109.8% -0.012 pp
    €44.36M +18.3% -€54.64M +487.0% -123.2% -0.98 pp -€48.15M -13.2% -108.5% +0.39 pp
    €37.50M +150.1% -€9.31M -93.2% -24.8% +8.9 pp -€55.45M +22.1% -147.9% +1.6 pp
    €14.99M +311.7% -€137.53M +77.5% -917.3% +12 pp -€45.41M -30.0% -302.9% +15 pp
    €3.64M +112.4% -€77.48M +55.9% -2,127.6% +7.7 pp -€64.91M +59.2% -1,782.4% +6.0 pp
    €1.71M +3.5% -€49.70M -9.0% -2,899.1% +4.0 pp -€40.78M +12.1% -2,378.8% -1.8 pp
    €1.66M +1.9% -€54.61M +41.8% -3,296.2% -9.3 pp -€36.38M +31.6% -2,195.6% -5.0 pp
    €1.63M +7.8% -€38.51M +12.5% -2,369.0% -0.98 pp -€27.64M +0.4% -1,700.2% +1.3 pp
    €1.51M +126.7% -€34.24M +38.7% -2,271.3% +14 pp -€27.54M +66.2% -1,826.6% +6.7 pp
    €665.12K +∞% -€24.68M +115.1% -3,710.9% -37 pp -€16.57M +56.9% -2,491.7% -25 pp
    €0.00 -100.0% -€11.47M -5.5% N/A -€10.56M -1.0% N/A
    €8.62K -€12.14M -140,930.0% -€10.67M -123,820.0%

    Notifications